A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

A novel survival-based tissue microarray of pancreatic cancer validates MUC1 and mesothelin as biomarkers.

One-fifth of patients with seemingly 'curable' pancreatic ductal adenocarcinoma (PDA) experience an early recurrence and death, receiving no definable benefit from a major operation. Some patients with advanced stage tumors are deemed 'unresectable' by conventional staging criter...

Full description

Bibliographic Details
Main Authors: Jordan M Winter, Laura H Tang, David S Klimstra, Murray F Brennan, Jonathan R Brody, Flavio G Rocha, Xiaoyu Jia, Li-Xuan Qin, Michael I D'Angelica, Ronald P DeMatteo, Yuman Fong, William R Jarnagin, Eileen M O'Reilly, Peter J Allen
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2012-01-01
Series:PLoS ONE
Online Access:http://europepmc.org/articles/PMC3391218?pdf=render

Internet

http://europepmc.org/articles/PMC3391218?pdf=render

Similar Items